LMR Partners’s Hims & Hers Health HIMS Stock Holding History

LMR Partners’s Portfolio HIMS Stock Details HIMS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-10,000	Closed	-$567K	–	1610
2025 Q3	$567K	Sell	10,000 -10,000	-50%	-$512K	﹤0.01%	1070
2025 Q2	$997K	Buy	+20,000	New	+$904K	0.01%	796

Other funds holding HIMS

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Defiance ETFs New York $6.98B AUM

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

LMR Partners's HIMS Position: Q1 2026 in Review

LMR Partners sold out of Hims & Hers Health (HIMS) in Q1 2026, closing a stake of 370,152 shares — an estimated $12M sold.

LMR Partners first reported a position in HIMS in Q3 2019 and held it in 11 quarters. The position peaked at $16.1M in Q3 2025. 434 funds tracked by Wall St. Rank hold HIMS as of Q1 2026.

LMR Partners reported no remaining Hims & Hers Health position as of Q1 2026 after selling out during the quarter.
LMR Partners sold 370,152 Hims & Hers Health shares in Q1 2026, an estimated $12M.
LMR Partners first reported a position in Hims & Hers Health in Q3 2019 and held it in 11 quarters.
LMR Partners's Hims & Hers Health position peaked at $16.1M in Q3 2025.
434 funds tracked by Wall St. Rank held Hims & Hers Health as of Q1 2026.

Based on LMR Partners's 13F filing for Q1 2026, filed 15 May 2026.